Skip to main content
. 2015 Jun;100(6):786–793. doi: 10.3324/haematol.2014.123273

Table 2.

Comparative incidence of isolated or multiple and recurrent neurotoxic adverse events due to intrathecal CNS prophylaxis in (A) the ITT and ITD study arms, and in (B) the ITD versus dexamethasone/ITD subgroups of the ITD study arm. GI-IV denotes increasing grades of neurotoxicity according to the CTC evaluation scale.

graphic file with name 100786.tab2.jpg